Melissa Tomkiel Sells 29,730 Shares of Strata Critical Medical (NASDAQ:SRTA) Stock

Posted by George Bondi on Jun 12th, 2026

Strata Critical Medical (NASDAQ:SRTA – Get Free Report) CEO Melissa Tomkiel sold 29,730 shares of the firm’s stock in a transaction that occurred on Monday, June 8th. The stock was sold at an average price of $5.87, for a total transaction of $174,515.10. Following the transaction, the chief executive officer directly owned 1,892,774 shares in the company, valued at approximately $11,110,583.38. This trade represents a 1.55% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Strata Critical Medical Trading Up 0.2%

Shares of SRTA stock opened at $5.49 on Friday. The stock has a market capitalization of $475.03 million, a price-to-earnings ratio of -68.63 and a beta of 2.20. The company’s 50 day simple moving average is $5.19. Strata Critical Medical has a 52-week low of $3.57 and a 52-week high of $6.50.

Strata Critical Medical (NASDAQ:SRTA – Get Free Report) last issued its quarterly earnings data on Wednesday, May 6th. The company reported $0.03 earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.04) by $0.07. The company had revenue of $67.38 million for the quarter. Strata Critical Medical had a net margin of 20.56% and a negative return on equity of 4.06%. On average, analysts anticipate that Strata Critical Medical will post -0.14 EPS for the current fiscal year.

Institutional Investors Weigh In On Strata Critical Medical

Institutional investors and hedge funds have recently made changes to their positions in the stock. Granite Investment Partners LLC lifted its stake in shares of Strata Critical Medical by 77.0% during the first quarter. Granite Investment Partners LLC now owns 18,181 shares of the company’s stock worth $76,000 after buying an additional 7,911 shares during the period. Seelaus Asset Management LLC lifted its stake in shares of Strata Critical Medical by 32.7% during the first quarter. Seelaus Asset Management LLC now owns 24,350 shares of the company’s stock worth $102,000 after buying an additional 6,000 shares during the period. Principal Financial Group Inc. acquired a new stake in shares of Strata Critical Medical during the first quarter worth $537,000. Quantinno Capital Management LP lifted its stake in shares of Strata Critical Medical by 98.7% during the first quarter. Quantinno Capital Management LP now owns 143,239 shares of the company’s stock worth $599,000 after buying an additional 71,155 shares during the period. Finally, Bank of America Corp DE lifted its stake in shares of Strata Critical Medical by 16.2% during the first quarter. Bank of America Corp DE now owns 181,574 shares of the company’s stock worth $759,000 after buying an additional 25,379 shares during the period. 47.36% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several equities analysts recently issued reports on SRTA shares. Zacks Research raised shares of Strata Critical Medical to a “hold” rating in a report on Thursday, March 26th. Weiss Ratings raised shares of Strata Critical Medical from a “hold (c-)” rating to a “hold (c)” rating in a report on Monday, May 11th. B. Riley Financial started coverage on shares of Strata Critical Medical in a report on Wednesday, March 25th. They set a “buy” rating and a $8.00 price objective on the stock. Finally, Craig Hallum started coverage on shares of Strata Critical Medical in a report on Wednesday, March 25th. They set a “buy” rating and a $8.00 price objective on the stock. One investment analyst has rated the stock with a Strong Buy rating, one has issued a Buy rating and two have issued a Hold rating to the company. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $8.00.

View Our Latest Report on SRTA

About Strata Critical Medical

(Get Free Report)

Blade Air Mobility, Inc provides air transportation alternatives to the congested ground routes in the United States. It provides its services through charter and by-the-seat flights using helicopters, jets, turboprops, and amphibious seaplanes. The company was founded in 2014 and is headquartered in New York, New York.